Cargando…

Characterizing the COVID-19 illness experience to inform the study of post-acute sequelae and recovery: a qualitative study

We aimed to characterize the variability in the illness experience and recovery process from COVID-19. We conducted in-depth individual interviews with participants enrolled in the Long-term Immunological Impact of Novel Coronavirus (LIINC) cohort study in San Francisco, California from June through...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santiago-Rodriguez, Edda I., Maiorana, Andres, Peluso, Michael J., Hoh, Rebecca, Tai, Viva, Fehrman, Emily A., Hernandez, Yanel, Torres, Leonel, Spinelli, Matthew A., Gandhi, Monica, Kelly, J. Daniel, Martin, Jeffrey N., Henrich, Timothy J., Deeks, Steven G., Sauceda, John A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7987040/ https://www.ncbi.nlm.nih.gov/pubmed/33758881 http://dx.doi.org/10.1101/2021.03.10.21253330

Ejemplares similares

Characterizing the COVID-19 Illness Experience to Inform the Study of Post-acute Sequelae and Recovery
por: Santiago-Rodriguez, Edda I., et al.
Publicado: (2021)

Rapid implementation of a cohort for the study of post-acute sequelae of SARS-CoV-2 infection/COVID-19
por: Peluso, Michael J., et al.
Publicado: (2021)

Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms
por: Peluso, Michael J., et al.
Publicado: (2021)

Long-Term SARS-CoV-2-Specific Immune and Inflammatory Responses Across a Clinically Diverse Cohort of Individuals Recovering from COVID-19
por: Peluso, Michael J., et al.
Publicado: (2021)

Differences in Post-mRNA Vaccination Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunoglobulin G (IgG) Concentrations and Surrogate Virus Neutralization Test Response by Human Immunodeficiency Virus (HIV) Status and Type of Vaccine: A Matched Case-Control Observational Study
por: Spinelli, Matthew A, et al.
Publicado: (2021)

LB8. Lower SARS-CoV-2 IgG and Pseudovirus Neutralization Titers Post-mRNA Vaccination among People Living with HIV
por: Spinelli, Matthew A, et al.
Publicado: (2021)

Plasma Markers of Neurologic Injury and Inflammation in People With Self-Reported Neurologic Postacute Sequelae of SARS-CoV-2 Infection
por: Peluso, Michael J., et al.
Publicado: (2022)

CE-541-04 CARDIAC ARRHYTHMIAS IN POST-ACUTE SEQUELAE OF SARS-COV-2 INFECTION ASSESSED BY AMBULATORY RHYTHM MONITORING
por: Hill, Christopher, et al.
Publicado: (2022)

SARS-CoV-2 serology across scales: a framework for unbiased seroprevalence estimation incorporating antibody kinetics and epidemic recency
por: Takahashi, Saki, et al.
Publicado: (2021)

SARS-CoV-2 Serology Across Scales: A Framework for Unbiased Estimation of Cumulative Incidence Incorporating Antibody Kinetics and Epidemic Recency
por: Takahashi, Saki, et al.
Publicado: (2023)

“Holidays Come, Sundays Come. It is Very Sad to be Alone”: Transnational Practices and the Importance of Family for Mexican and Puerto Rican Latinxs Living with HIV in the Continental U.S.
por: Maiorana, Andres, et al.
Publicado: (2020)

Persistence, Magnitude, and Patterns of Postacute Symptoms and Quality of Life Following Onset of SARS-CoV-2 Infection: Cohort Description and Approaches for Measurement
por: Peluso, Michael J, et al.
Publicado: (2021)

A collaborative, multidisciplinary approach to HIV transmission risk mitigation during analytic treatment interruption
por: Peluso, Michael J, et al.
Publicado: (2020)

SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay
por: Peluso, Michael J., et al.
Publicado: (2021)

SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay
por: Peluso, Michael J., et al.
Publicado: (2021)

SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study
por: Spinelli, Matthew A, et al.
Publicado: (2021)

Considerations for designing and implementing combination HIV cure trials: findings from a qualitative in-depth interview study in the United States
por: Dubé, Karine, et al.
Publicado: (2021)

SARS-CoV-2 Vaccination in the Context of Ongoing HIV Cure-Related Research Studies
por: Peluso, Michael J., et al.
Publicado: (2021)

Operationalizing Human Immunodeficiency Virus Cure-related Trials with Analytic Treatment Interruptions During the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic: A Collaborative Approach
por: Peluso, Michael J, et al.
Publicado: (2020)

A High Percentage of People With Human Immunodeficiency Virus (HIV) on Antiretroviral Therapy Experience Detectable Low-Level Plasma HIV-1 RNA Following Coronavirus Disease 2019 (COVID-19)
por: Peluso, Michael J, et al.
Publicado: (2020)

Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-κB signaling
por: Giron, Leila B., et al.
Publicado: (2022)

Markers of fungal translocation are elevated during post-acute sequelae of SARS-CoV-2 and induce NF-κB signaling
por: Giron, Leila B., et al.
Publicado: (2022)

Cost of Illness for Five Major Foodborne Illnesses and Sequelae in Sweden
por: Sundström, Kristian
Publicado: (2018)

Effect of Oral Nirmatrelvir on Long COVID Symptoms: 4 Cases and Rationale for Systematic Studies
por: Peluso, Michael J., et al.
Publicado: (2022)

Postacute Sequelae of COVID-19 Critical Illness
por: Schwab, Kristin, et al.
Publicado: (2022)

Impact of Pre-Existing Chronic Viral Infection and Reactivation on the Development of Long COVID
por: Peluso, Michael J., et al.
Publicado: (2022)

Chronic viral coinfections differentially affect the likelihood of developing long COVID
por: Peluso, Michael J., et al.
Publicado: (2023)

Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC)
por: Sherif, Zaki A, et al.
Publicado: (2023)

Role of antibodies, inflammatory markers, and echocardiographic findings in postacute cardiopulmonary symptoms after SARS-CoV-2 infection
por: Durstenfeld, Matthew S., et al.
Publicado: (2022)

Voice Sequelae Following Recovery From COVID-19
por: Romero Arias, Tatiana, et al.
Publicado: (2022)

HIV and mental illness in Malawi and the neuropsychiatric sequelae of efavirenz
por: Drury, Andrew, et al.
Publicado: (2018)

Critical Illness Polyneuropathy as a Sequelae of COVID-19
por: Bawiskar, Nipun, et al.
Publicado: (2022)

Long-term sequelae of critical illness: memories and health-related quality of life
por: Hough, Catherine Lee, et al.
Publicado: (2005)

Discordant Virus-Specific Antibody Levels, Antibody Neutralization Capacity, and T-cell Responses Following 3 Doses of SARS-CoV-2 Vaccination in a Patient With Connective Tissue Disease
por: Peluso, Michael J, et al.
Publicado: (2021)

Chronic sequelae of foodborne disease.
por: Lindsay, J A
Publicado: (1997)

Estimating the cost of illness of acute Japanese encephalitis and sequelae care in Vietnam and Laos: A cross-sectional study
por: Nguyen, An Le Thanh, et al.
Publicado: (2023)

Ethical and practical considerations for cell and gene therapy toward an HIV cure: findings from a qualitative in-depth interview study in the United States
por: Dubé, Karine, et al.
Publicado: (2022)

Recovery and sequelae in 523 adults and children with tick-borne encephalitis in Germany
por: Nygren, Teresa M., et al.
Publicado: (2023)

Recovery of Renal Function after One-Year of Dialysis Treatment: Case Report and Registry Data
por: Fehrman-Ekholm, Ingela, et al.
Publicado: (2010)

Early clues regarding the pathogenesis of long-COVID
por: Peluso, Michael J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vtsrqhk62ceqeurhbq2127s1ta